LYMPHADENOPATHY

Clinical trials for LYMPHADENOPATHY explained in plain language.

Never miss a new study

Get alerted when new LYMPHADENOPATHY trials appear

Sign up with your email to follow new studies for LYMPHADENOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 3 Completed 1

Experimental antibody shows promise for rare amyloid disease

Disease control Completed

This phase II trial tested the drug isatuximab in 43 patients with AL amyloidosis that had come back or stopped responding to treatment. Isatuximab is a monoclonal antibody that may help stop abnormal protein buildup. The study measured how well the drug reduced disease markers a…

Matched conditions: LYMPHADENOPATHY

Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control

Last updated Jun 26, 2026 15:04 UTC

LYMPHADENOPATHY

Get alerted when new LYMPHADENOPATHY trials appear

Experimental antibody shows promise for rare amyloid disease